Medifocus (CVE:MFS) Stock Price Down 50%

Share on StockTwits

Medifocus Inc. (CVE:MFS)’s stock price dropped 50% during mid-day trading on Friday . The stock traded as low as C$0.01 and last traded at C$0.01, approximately 542,000 shares traded hands during mid-day trading. An increase of 26% from the average daily volume of 430,675 shares. The stock had previously closed at C$0.01.

The company has a market capitalization of $1.85 million and a price-to-earnings ratio of -0.50. The firm has a 50 day simple moving average of C$0.01.

Medifocus Company Profile (CVE:MFS)

Medifocus Inc, a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue.

Further Reading: Initial Coin Offerings entail a high degree of risk

Receive News & Ratings for Medifocus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifocus and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Obsidian Energy   Shares Down 11.1%
Obsidian Energy Shares Down 11.1%
Genesis Metals  Stock Price Down 10.4%
Genesis Metals Stock Price Down 10.4%
Benton Resources  Stock Price Down 10%
Benton Resources Stock Price Down 10%
Adaptimmune Therapeutics  Sets New 52-Week High at $6.04
Adaptimmune Therapeutics Sets New 52-Week High at $6.04
Datadog  Reaches New 12-Month High at $73.78
Datadog Reaches New 12-Month High at $73.78
Centerra Gold  Hits New 1-Year High on Analyst Upgrade
Centerra Gold Hits New 1-Year High on Analyst Upgrade


© 2006-2020 Ticker Report